The technology consists of a portable sample reparation platform that enables high‐efficiency virus enrichment from field samples (from cotton swabs and tissue biopsy), without using any antibody. The platform allows the specific capture of viral particles while removing host or sample contaminates. Viruses of interest are trapped by carefully tuning the filter pore size.
Proof‐of‐concept studies have demonstrated the platform to be compatible with plant, animal and human samples. The Technology Readiness Level for both indications is estimated to be a 5/9. During initial studies the USDA has validated the test for the diagnosis of Plum Pox Virus. Soon to be published experiments additionally validate the test for the capture (and subsequent NGS analysis) of Avian Influenza.
Mauricio Terrones, Ph.D
President
mterrones@virolock.com
Yin-Ting Yeh, Ph.D
Co-Founder
Nestor Perea‐Lopez, Ph.D
Co-Founder
nperea@virolock.com
Please send us a message or call us for an appointment.
200 innovation Boulevard, Sute 260B, State College, Pennsylvania 16801, United States
Virolock Technologies
200 innovation Boulevard, Sute 260B, State College, Pennsylvania 16801, United States